Felicia Chung Fei Lei

Designation/Title: Lecturer
Department: Institute for Research, Development and Innovation (IRDI), International Medical University
Tel: 03-27317215
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it


Education and Training

PhD Monash University 2014
BSc Monash University 2009


Research interests:

  • Cancer cell biology
  • Cancer epigenetics


Research projects/grants:

  • Functional role of p21 protein-activated kinase 4 (PAK4) in invasive oral squamous cell carcinoma – MoHE, FRGS, Malaysia (Principal investigator)
  • Effectors of GATA4 epigenetic silencing - Toray Science Foundation, Japan (Principal investigator)


Supervision of Postgraduates (MSc/PhD)
(Last 5 years – 2010-2014)

  • Functional role of p21 protein-activated kinase 4 (PAK4) in invasive oral squamous cell carcinoma –Ms. Tan Si Hoey, MSc Project, (2015 – present). (Co-supervisor)
  • Targeting breast cancer stem cells and non-stem breast cancer cells through combination therapies - Ms. Hii Ling Wei, MSc Project, (2014 – present). (Co-supervisor)
  • Identification of new molecular targets for treatment of endometrial cancers – Mr. Lim Wei Meng, PhD Project (2015 – present). (Co-supervisor)


Professional affiliations:



Academic Awards:

  • AVON-AACR Scholar-in-Training Travel Award to the San Antonio Breast Cancer Symposium (2012)
  • Best Graduate Award – Bachelor of Science (Biotechnology) Honours (2009) – Monash University Sunway Campus
  • Highest Academic Performance (Genomics and Molecular Genetics) (2008) – Monash University Sunway Campus


Recent publications
(last 5 years – 2010 -2014)

  • Fei-Lei Chung, F., Wai Mai, C., Yuen Ng, P., and Leong, C.-O. (2015). Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers. Curr. Cancer Drug Targets 16, 71–78.
  • Soo, J.S.-S., Ng, C.-H., Tan, S.H., Malik, R.A., Teh, Y.-C., Tan, B.-S., Ho, G.-F., See, M.-H., Taib, N.A.M., Yip, C.-H., et al. (2015). Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells. Apoptosis Int. J. Program. Cell Death 20, 1373–1387.
  • Tan, B.S., Tiong, K.H., Choo, H.L., Fei-Lei Chung, F., Hii, L.-W., Tan, S.H., Yap, I.K., Pani, S., Khor, N.T., Wong, S.F., et al. (2015). Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF). Cell Death Dis. 6, e1826.
  • Ong, L.-C., Chung, F.-L., Tan, Y.-F., & Leong, C.-O. (2014). Toxicity of single-walled carbon nanotubes. Archives of Toxicology, 1–16.
  • Wang, Y., Chung, F., Lee, S., & Dykes, G. (2013). Inhibition of attachment of oral bacteria to immortalized human gingival fibroblasts (HGF-1) by tea extracts and tea components. BMC Research Notes, 6(1), 143.



MS ISO/IEC 17025